Photo: Ida Marie Odgaard/Ritzau Scanpix/Sipa USA/Sipa via AP Images
May 31, 2023 02:42 PM EDT
Pharma
FDA+
Manufacturing

FDA warns about com­pound­ed semaglu­tide-based drugs

Tyler Patchen

News Reporter

The FDA has warned the pub­lic that com­pound­ed ver­sions of pop­u­lar GLP-1 drugs Ozem­pic and We­govy may not in­clude the same in­gre­di­ents as the pre­scrip­tion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Bris­tol My­er­s' schiz­o­phre­nia drug fails Phase 3 tri­al for ad­junc­tive treat­ment

As­cle­tis posts puz­zling Phase 1 up­date on obe­si­ty pill

Chi­na’s biotech mar­ket is stag­ing a come­back that US biotech can on­ly wish for

Genen­tech vet launch­es ADC start­up with $20M

With aims to be­come a 'gen­er­a­tional biotech,' Zealand Phar­ma hires Lil­ly vet­er­an as sci­ence chief

sponsored

AD­STI­LADRIN® (nad­o­fara­gene fi­rade­n­ovec-vncg) – A Grow­ing Body of Clin­i­cal Da­ta and Re­al-World Ev­i­dence

A service from the Financial Times